Additionally we selected SCF, and BDNF, as their receptors KIT and NTRK2 high expression is associated with poor NB survival (Fig. S2a), and these growth factor has reported ability to protect NB cells from anticancer drugs [34, 35]. Here, KITLG is linked to neuroblastoma.